Center for Scientific Review; Notice of Closed Meetings, 20117-20118 [06-3707]

Download as PDF Federal Register / Vol. 71, No. 75 / Wednesday, April 19, 2006 / Notices amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Understanding Achievement Gaps and Developing Interventions to Close Them. Date: April 25, 2006. Time: 8:30 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Washington, Pennsylvania Ave. at 15th Street, NW., Washington, DC 20004. Contact Person: Marita R. Hopmann, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, 6100 Building, Room 5B01, Bethesda, MD 20892, (301) 435–6911, hopmannm@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Biomedical Library and Informatics Review Committee. Date: June 15–16, 2006. Time: June 15, 2006, 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892. Time: June 16, 2006, 8 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20892. Contact Person: Arthur A. Petrosian, PhD, Scientific Review Administrator, Division of Extramural Programs, National Library of Medicine, 6705 Rockledge Drive, Suite 301, Bethesda, MD 20892–7968, 301–496–4253, petrosia@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.879, Medical Library Assistance, National Institutes of Health, HHS). Dated: April 11, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–3700 Filed 4–18–06; 8:45 am] (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: April 12, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–3710 Filed 4–18–06; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M Notice is hereby given of a meeting scheduled by the Deputy Director for Intramural Research at the National Institutes of Health (NIH) with the Chairpersons of the Boards of Scientific Counselors. The Boards of Scientific Counselors are advisory groups to the Scientific Directors of the Intramural Research Programs at the NIH. This meeting will take place on May 12, 2006, from 10 a.m. to 3 p.m., at the NIH, 9000 Rockville Pike, Bethesda, MD, Building 1, Room 151. The meeting will include a discussion of policies and procedures that apply to the regular review of NIH intramural scientists and their work, with special emphasis on clinical research. The meeting will be open to the public, with attendance limited to space DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health cchase on PROD1PC60 with NOTICES National Library of Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and VerDate Aug<31>2005 17:09 Apr 18, 2006 Jkt 208001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Meeting; Chairpersons, Boards of Scientific Counselors for Institutes and Centers at the National Institutes of Health PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 20117 available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should contact Ms. Colleen Crone at the Office of Intramural Research, NIH, Building 1, Room 160, Telephone (301) 496–1921 or FAX (301) 402–4273 in advance of the meeting. Dated: April 5, 2006. Raynard Kington, Deputy Director, NIH. [FR Doc. 06–3702 Filed 4–18–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Viral Dangers to Immunocompromised Patients. Date: April 19, 2006. Time: 3 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Alexander D. Politis, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892, (301) 435– 1150, politisa@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Bioengineering Research Partnerships. Date: May 30, 2006. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\19APN1.SGM 19APN1 20118 Federal Register / Vol. 71, No. 75 / Wednesday, April 19, 2006 / Notices Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Khalid Masood, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5095H, MSC 7854, Bethesda, MD 20892, (301) 402– 3962, masoodk@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 12, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–3707 Filed 4–18–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, April 20, 2006, 3 p.m. to April 20, 2006, 4 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, which was published in the Federal Register on March 30, 2006, 71 FR 16173–16174. The meeting title has been changed to ‘‘Special Topic: Immunology’’. The meeting is closed to the public. Dated: April 12, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–3708 Filed 4–18–06; 8:45 am] DEPARTMENT OF HOMELAND SECURITY Transportation Security Administration Intent To Request Revision From OMB of One Current Public Collection of Information: Transportation Security Officer (TSO) Medical Questionnaire Transportation Security Administration (TSA), DHS. ACTION: Notice. cchase on PROD1PC60 with NOTICES AGENCY: SUMMARY: TSA invites public comment on one currently approved information collection requirement abstracted below that we will submit to the Office of Management and Budget (OMB) for 17:09 Apr 18, 2006 Jkt 208001 Comments Invited In accordance with the Paperwork Reduction Act of 1995, (44 U.S.C. 3501 et seq.), an agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a valid OMB control number. Therefore, in preparation for OMB review and approval of the following information collection, TSA is soliciting comments to: (1) Evaluate whether the proposed information requirement is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including using appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Information Collection Requirement BILLING CODE 4140–01–M VerDate Aug<31>2005 revision in compliance with the Paperwork Reduction Act. DATES: Send your comments by June 19, 2006. ADDRESSES: Katrina Wawer, AttorneyAdvisor, Office of Chief Counsel, TSA– 2, Transportation Security Administration, 601 South 12th Street, Arlington, VA 22202–4220. FOR FURTHER INFORMATION CONTACT: Katrina Wawer at the above address or by telephone (571) 227–1995 or facsimile (571) 227–1381. SUPPLEMENTARY INFORMATION: 1652–0032; Transportation Security Officer (formerly Screener) (TSO) Medical Questionnaire. Because Transportation Security Screeners were converted to Transportation Security Officers (TSOs) on February 5, 2005, TSA is revising the title of this collection accordingly. TSA also is making other revisions to the form to ensure the proper information is collected in the most appropriate manner. With approval from OMB, TSA currently collects information via a TSO medical questionnaire, which assists the agency in ensuring that candidates under employment consideration for TSO positions meet the qualification standards to successfully perform the functions of the position. TSA uses this information to evaluate a candidate’s physical and medical qualifications, including visual and aural acuity, and physical coordination and motor skills. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 TSA now seeks approval to revise its existing control number application to include additional medical forms which TSA candidates will bring with them to follow-up medical evaluations (should they be necessary) and which must be completed by the candidate’s health care provider(s) and returned to TSA by facsimile. These forms are required in circumstances where additional medical information is needed to make a determination regarding the candidate’s qualifications for the TSO job. For example, due to the physically demanding nature of the TSO job, it is important to ensure that individuals who have prior back injuries are evaluated thoroughly to ensure they can perform the TSO job safely and efficiently without excessive risk of accident or injury to themselves or others. This additional information is provided by the candidate’s health care provider of choice and includes historical and other information needed to make a determination. A TSA contractor will facilitate receipt and processing of these forms. The variety of forms pertains to particular body systems and medical conditions, including cardiac, orthopedic, endocrine, vitals, etc. The form or forms a candidate’s health care provider will complete depends on the condition(s) revealed during a candidate’s initial medical evaluation. Thus, while all candidates reaching the medical evaluation portion of the selection process will be asked to complete a medical questionnaire, only candidates for whom additional information is needed will be asked to seek further evaluation from their health care provider and submit additional information through the further evaluation forms. Historical data indicate that approximately 30 percent of candidates reaching the medical evaluation will be required to complete an additional form(s). TSA estimates that the potential annual respondent population for this collection will be 22,800 health care providers and candidates, which includes 11,400 candidates and 11,400 health care providers, nationwide. TSA estimates the total annual hour burden, in addition to the annual burden as a result of the TSO medical questionnaire, to be 6346 hours. Issued in Arlington, Virginia, on April 12, 2006. Lisa S. Dean, Privacy Officer. [FR Doc. E6–5840 Filed 4–18–06; 8:45 am] BILLING CODE 4910–62–P E:\FR\FM\19APN1.SGM 19APN1

Agencies

[Federal Register Volume 71, Number 75 (Wednesday, April 19, 2006)]
[Notices]
[Pages 20117-20118]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-3707]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Viral Dangers to Immunocompromised Patients.
    Date: April 19, 2006.
    Time: 3 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Alexander D. Politis, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 
20892, (301) 435-1150, politisa@csr.nih.gov.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Bioengineering Research Partnerships.
    Date: May 30, 2006.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 20118]]

    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Khalid Masood, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5095H, MSC 7854, Bethesda, MD 
20892, (301) 402-3962, masoodk@csr.nih.gov.


(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: April 12, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.


[FR Doc. 06-3707 Filed 4-18-06; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.